Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Assets Average (2020 - 2025)

Burning Rock Biotech has reported Assets Average over the past 6 years, most recently at $114.9 million for Q4 2025.

  • For Q4 2025, Assets Average fell 12.83% year-over-year to $114.9 million; the TTM value through Dec 2025 reached $114.9 million, down 12.83%, while the annual FY2025 figure was $119.3 million, 10.89% down from the prior year.
  • Assets Average for Q4 2025 was $114.9 million at Burning Rock Biotech, roughly flat from $114.6 million in the prior quarter.
  • Over five years, Assets Average peaked at $405.6 million in Q1 2021 and troughed at $114.6 million in Q3 2025.
  • A 5-year average of $222.7 million and a median of $183.3 million in 2023 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: decreased 7.15% in 2021 and later plummeted 37.64% in 2023.
  • Year by year, Assets Average stood at $366.5 million in 2021, then crashed by 36.34% to $233.3 million in 2022, then plummeted by 34.77% to $152.2 million in 2023, then dropped by 13.4% to $131.8 million in 2024, then dropped by 12.83% to $114.9 million in 2025.
  • Business Quant data shows Assets Average for BNR at $114.9 million in Q4 2025, $114.6 million in Q3 2025, and $116.5 million in Q2 2025.